Pharmafile Logo

Webcast: How to improve the patient journey through an effective engagement and activation strategy

Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.

The global pandemic has caused the health and life science industry to change more in the last three years than it has in the last three decades. The accelerated adoption of digital in all areas of the healthcare landscape has dramatically altered the patient journey.  Now more than ever, healthcare stakeholders need support from pharma to help deliver optimal care to patients.  But are current engagement strategies working as well as they could be?

Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.

Using a typical product profile scenario in an area of high unmet need, they will demonstrate how pharmaceutical manufacturers can improve the patient journey through a combination of insight generation, engagement strategy and activation.

Research Partnership Director, Liza Pliss was joined by Nareda Mills, Global President, Patient Solutions at Ashfield Engage and Edward Gajewski, Principal at Nuvera Life Science Consulting.

They will share best-practice and practical insight on how to develop suitable research programs, strategies and initiatives that successfully support stakeholders throughout the journey, improve brand engagement and ultimately improve patient outcomes.

What you will learn:

  • How to gather the right insights for early commercialization and to guide the design of clinical trials
  • How to gain a foundational patient understanding in a new disease area or for a new asset in an area of unmet need
  • How to get a deeper understanding of the changing emotional needs of patients and their new digital behaviours in areas of chronic illness
  • How to deploy engagement tactics throughout the journey and product lifecycle

Watch here

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

20 questions: Round 1

As it's our 20th year anniversary, we invited our employees to play 20 questions - this month "What's the biggest challenge you've overcome at Research Partnership?"Watch the video: https://www.researchpartnership.com/news/2017/03/20-questions-round-1/

Brand tracking research

A common challenge for brand tracking is ensuring the research programme stays relevant to the brand’s current environment. In this video Quantitative Research Directors Karen Swords and Vicky McLellan outline...

Pharma China Annual Forum 2017

We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.

Healthcare Market Research in the Gulf: 3 lessons I’ve learned

A few key considerations for conducting healthcare market research in the Gulf

Case study: Multiple Sclerosis new medical device research

Our client wanted to find out how best to develop an implantable delivery device technology with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a...

Patient Centricity: Turning Rhetoric into Reality

Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST

Making sense of Nutraceuticals in China

Published in eyeforpharma February 2017 by Marc Yates

Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research...

Women’s health in emerging markets

Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and...

Research Partnership has published a new Living with Lupus (SLE) market report for 2017

SLE is a progressive and debilitating disease which affects 5 million people worldwide.